WebApr 19, 2024 · SAN FRANCISCO, April 19, 2024--Unlearn works with pharma sponsors, biotech companies, and academic institutions to optimize human clinical trials with TwinRCTs™.

Unlearn Receives Draft Qualification Opinion from European …

WebSep 28, 2024 · Unlearn®, the only artificial intelligence (AI) company developing prognostic digital twins to run smaller, faster clinical trials, today announced that the European Medicines Agency (EMA) has released its final favorable qualification opinion providing a regulatory framework for the application of the company’s TwinRCT™ solution in Phase ... WebMar 31, 2024 · Nevertheless, our TwinRCT solution powered by PROCOVA is a big step in the right direction— enabling smaller, faster trials that ultimately reduce the time it takes to … chrystia freeland budget speech 2022

Unlearn.AI - Alliance Manager

WebApr 2, 2024 · Unlearn has invented a type of randomized controlled trial called a TwinRCT, which generates reliable evidence while enabling the use of smaller control groups than traditional trials. TwinRCTs complete enrollment in less time, are more patient-centric, and provide a regulatory-approved method for using machine learning-based prognostic … WebUnlearn invented their TwinRCT solution to enable biopharma partners to run faster, more successful clinical trials. A TwinRCT is a randomized trial that uses machine learning to … WebA TwinRCT allows more trial patients to receive the experimental treatment, reaches full enrollment faster and put patients first. Unlearn’s innovative work in AI today will reinvent how AI is applied in medicine tomorrow—and we have a top secret plan for how to get there. chrystia freeland cancel disney